Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H.
Uchimoto T, et al. Among authors: yamamoto y.
Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02709-1. Online ahead of print.
Int J Clin Oncol. 2025.
PMID: 39890750